Clinical Trials Directory

Trials / Completed

CompletedNCT05196997

The De-Morton Mobility Index Turkish Version in Intensive Care Patients

Construct Validity and Test-Retest Reliability of The De-Morton Mobility Index Turkish Version in Intensive Care Patients

Status
Completed
Phase
Study type
Observational
Enrollment
150 (actual)
Sponsor
Izmir Katip Celebi University · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers

Summary

De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit.

Detailed description

De Morton Mobility Index is recommended for the evaluation of mobility in the evidence-based guidelines, in patients in intensive care units. The aim of our study is to examine the validity and reliability of the Turkish version of the De Morton Mobility Index in patients hospitalized in the respiratory intensive care unit. Patients aged 18 years and over who were discharged from the ICU were included in our study. We used De-Morton Mobility Index, Bartel Index, Katz Activities of Daily Living Rating Scale and MRC Muscle Strength Test for convergent validity. De-Morton Mobility assessment for test-retest reliability was performed again on the 1st day of the patient's service.

Conditions

Interventions

TypeNameDescription
OTHERMobility and Functional AssessmentsThe first evaluation was made on the day the patient was discharged from the intensive care unit. DEMMI, Bartel Index, Katz Activities of Daily Living Rating Scale and MRC Muscle Strength Test were performed to the patient, respectively. De-Morton Mobility assessment for test-retest reliability was performed again on the 1st day of the patient's service.

Timeline

Start date
2018-04-01
Primary completion
2019-02-20
Completion
2019-02-20
First posted
2022-01-19
Last updated
2022-01-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT05196997. Inclusion in this directory is not an endorsement.